Characterizing Circulating microRNA Signatures of Type 2 Diabetes Subtypes

• Published in: International journal of molecular sciences Vol. 26; no. 2; p. 637
• Main Authors: Sulaiman, Fatima, Khyriem, Costerwell, Dsouza, Stafny, Abdul, Fatima, Alkhnbashi, Omer, Faraji, Hanan, Farooqi, Muhammad, Al Awadi, Fatheya, Hassanein, Mohammed, Ahmed, Fayha, Alsharhan, Mouza, Tawfik, Abdel Rahman, Khamis, Amar Hassan, Bayoumi, Riad
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 14.01.2025; MDPI
• Subjects: Adult; Aged; Analysis; Biomarkers - blood; Body mass index; Case-Control Studies; Circulating MicroRNA - blood; Circulating MicroRNA - genetics; Cluster analysis; Computational Biology - methods; Diabetes; Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - classification; Diabetes Mellitus, Type 2 - genetics; Disease; DNA methylation; Drugs; Epigenetics; Expatriates; Fasting; Female; Gene expression; Gene Expression Profiling; Genes; Genomes; Glucose; Humans; Insulin; Insulin resistance; Insulin Resistance - genetics; Male; Metabolism; MicroRNA; MicroRNAs; MicroRNAs - blood; MicroRNAs - genetics; Middle Aged; Pathophysiology; Patients; RNA sequencing; Transcriptome; Type 2 diabetes; United Arab Emirates; Middle East; Type 2 diabetes; T2D subtypes; insulin resistance; circulating microRNA; pathophysiology
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms26020637

Type 2 diabetes (T2D) is a heterogeneous disease influenced by both genetic and environmental factors. Recent studies suggest that T2D subtypes may exhibit distinct gene expression profiles. In this study, we aimed to identify T2D cluster-specific miRNA expression signatures for the previously reported five clinical subtypes that characterize the underlying pathophysiology of long-standing T2D: severe insulin-resistant diabetes (SIRD), severe insulin-deficient diabetes (SIDD), mild age-related diabetes (MARD), mild obesity-related diabetes (MOD), and mild early-onset diabetes (MEOD). We analyzed the circulating microRNAs (miRNAs) in 45 subjects representing the five T2D clusters and 7 non-T2D healthy controls by single-end small RNA sequencing. Bioinformatic analyses identified a total of 430 known circulating miRNAs and 13 previously unreported novel miRNAs. Of these, 71 were upregulated and 37 were downregulated in either controls or individual clusters. Each T2D subtype was associated with a specific dysregulated miRNA profile, distinct from that of healthy controls. Specifically, 3 upregulated miRNAs were unique to SIRD, 1 to MARD, 9 to MOD, and 18 to MEOD. Among the downregulated miRNAs, 11 were specific to SIRD, 9 to SIDD, 2 to MARD, and 1 to MEOD. Our study confirms the heterogeneity of T2D, represented by distinguishable subtypes both clinically and epigenetically and highlights the potential of miRNAs as markers for distinguishing the pathophysiology of T2D subtypes.